Age 0 3 0 3 B-age
greater 4 11 4 11 O
than 12 16 12 16 O
or 17 19 17 19 O
equal 20 25 20 25 O
to18 26 30 26 30 O
Years 31 36 31 36 I-lower_bound

Altered 0 7 37 44 B-chronic_disease
mental 8 14 45 51 I-chronic_disease
state 15 20 52 57 I-chronic_disease

Anemia 0 6 58 64 B-chronic_disease
( 7 8 65 66 O
hemoglobin<12.0g 8 24 66 82 B-clinical_variable
/ 24 25 82 83 I-upper_bound
dL 25 27 83 85 I-upper_bound
) 27 28 85 86 O

Any 0 3 87 90 O
HIV 4 7 91 94 B-chronic_disease
status 8 14 95 101 O

Any 0 3 102 105 O
abnormality 4 15 106 117 O
that 16 20 118 122 O
would 21 26 123 128 O
be 27 29 129 131 O
scored 30 36 132 138 O
as 37 39 139 141 O
NCI 40 43 142 145 O
CTC 44 47 146 149 O
Grade 48 53 150 155 O
4 54 55 156 157 O
toxicity 56 64 158 166 O
that 65 69 167 171 O
is 70 72 172 174 O
unrelated 73 82 175 184 O
to 83 85 185 187 O
HIV 86 89 188 191 B-chronic_disease
, 89 90 191 192 O
its 91 94 193 196 O
treatment 95 104 197 206 O

At 0 2 207 209 O
least 3 8 210 215 O
two 9 12 216 219 B-lower_bound
manifestations 13 27 220 234 O
drawn 28 33 235 240 O
from 34 38 241 245 O
at 39 41 246 248 O
least 42 47 249 254 O
two 48 51 255 258 O
of 52 54 259 261 O
the 55 58 262 265 O
categories 59 69 266 276 O
( 70 71 277 278 O
clinical 71 79 278 286 O
symptoms 80 88 287 295 O
, 88 89 295 296 O
laboratory 90 100 297 307 O
abnormalities 101 114 308 321 O
and 115 118 322 325 O
radiographic 119 131 326 338 O
abnormalities 132 145 339 352 O
) 145 146 352 353 O
, 146 147 353 354 O
which 148 153 355 360 O
are 154 157 361 364 O
at 158 160 365 367 O
least 161 166 368 373 O
possibly 167 175 374 382 O
attributable 176 188 383 395 O
to 189 191 396 398 O
KICS 192 196 399 403 O
and 197 200 404 407 O
are 201 204 408 411 O
not 205 208 412 415 O
readily 209 216 416 423 O
explicable 217 227 424 434 O
from 228 232 435 439 O
known 233 238 440 445 O
medical 239 246 446 453 O
conditions 247 257 454 464 O
in 258 260 465 467 O
the 261 264 468 471 O
patient 265 272 472 479 O

Biopsy 0 6 480 486 B-treatment
proven 7 13 487 493 O
KSHV 14 18 494 498 B-chronic_disease
- 18 19 498 499 I-chronic_disease
associated 19 29 499 509 I-chronic_disease
MCD 30 33 510 513 I-chronic_disease
, 33 34 513 514 O
confirmed 35 44 515 524 O
in 45 47 525 527 O
the 48 51 528 531 O
Laboratory 52 62 532 542 O
of 63 65 543 545 O
Pathology 66 75 546 555 O
, 75 76 555 556 O
CCR 77 80 557 560 O
, 80 81 560 561 O
NCI 82 85 562 565 O

Body 0 4 566 570 O
cavity 5 11 571 577 O
effusions 12 21 578 587 O
not 22 25 588 591 O
caused 26 32 592 598 O
by 33 35 599 601 O
primary 36 43 602 609 B-cancer
effusion 44 52 610 618 I-cancer
lymphoma 53 61 619 627 I-cancer
nor 62 65 628 631 O
chylous 66 73 632 639 B-chronic_disease
effusions 74 83 640 649 I-chronic_disease
directly 84 92 650 658 O
related 93 100 659 666 O
to 101 103 667 669 O
lymphatic 104 113 670 679 B-chronic_disease
infiltration 114 126 680 692 I-chronic_disease
by 127 129 693 695 O
KS 130 132 696 698 O

C 0 1 699 700 B-clinical_variable
- 1 2 700 701 I-clinical_variable
reactive 2 10 701 709 I-clinical_variable
protein 11 18 710 717 I-clinical_variable
> 19 20 718 719 O
3mg 20 23 719 722 B-lower_bound
/ 23 24 722 723 I-lower_bound
L 24 25 723 724 I-lower_bound

Cachexia 0 8 725 733 B-chronic_disease
or 9 11 734 736 O
edema 12 17 737 742 B-chronic_disease

Coagulopathy 0 12 743 755 B-chronic_disease
( 13 14 756 757 O
PT 14 16 757 759 B-clinical_variable
or 17 19 760 762 I-clinical_variable
PTT 20 23 763 766 I-clinical_variable
> 24 25 767 768 O
1.5 25 28 768 771 B-lower_bound
times 29 34 772 777 I-lower_bound
upper 35 40 778 783 I-lower_bound
limit 41 46 784 789 I-lower_bound
of 47 49 790 792 I-lower_bound
normal 50 56 793 799 I-lower_bound
) 56 57 799 800 O

Cough 0 5 801 806 B-chronic_disease
, 5 6 806 807 O
dyspnea 7 14 808 815 B-chronic_disease
, 14 15 815 816 O
airway 16 22 817 823 B-chronic_disease
hyperreactivity 23 38 824 839 I-chronic_disease
, 38 39 839 840 O
or 40 42 841 843 O
nasal 43 48 844 849 B-chronic_disease
inflammation 49 61 850 862 I-chronic_disease

Exposure 0 8 863 871 O
risk 9 13 872 876 O
for 14 17 877 880 O
KSHV 18 22 881 885 B-chronic_disease
infection 23 32 886 895 I-chronic_disease
( 33 34 896 897 O
including 34 43 897 906 O
being 44 49 907 912 O
a 50 51 913 914 O
first 52 57 915 920 O
or 58 60 921 923 O
second 61 67 924 930 O
generation 68 78 931 941 O
immigrant 79 88 942 951 O
from 89 93 952 956 O
an 94 96 957 959 O
endemic 97 104 960 967 O
area 105 109 968 972 O
, 109 110 972 973 O
or 111 113 974 976 O
male 114 118 977 981 B-gender
- 118 119 981 982 O
to 119 121 982 984 O
- 121 122 984 985 O
male 122 126 985 989 O
sexual 127 133 990 996 O
activity 134 142 997 1005 O
) 142 143 1005 1006 O
or 144 146 1007 1009 O
evidence 147 155 1010 1018 O
of 156 158 1019 1021 O
KSHV 159 163 1022 1026 O
infection 164 173 1027 1036 O

Fever 0 5 1037 1042 B-clinical_variable
( 6 7 1043 1044 O
> 7 8 1044 1045 O
38 8 10 1045 1047 B-lower_bound
degrees 11 18 1048 1055 I-lower_bound
C 19 20 1056 1057 I-lower_bound
) 20 21 1057 1058 O

Hepatomegaly 0 12 1059 1071 B-clinical_variable
( 13 14 1072 1073 O
> 14 15 1073 1074 O
17 15 17 1074 1076 B-lower_bound
cm 17 19 1076 1078 I-lower_bound
in 20 22 1079 1081 O
the 23 26 1082 1085 O
longest 27 34 1086 1093 O
dimension 35 44 1094 1103 O
) 44 45 1103 1104 O

Hypoalbuminemia 0 15 1105 1120 B-chronic_disease
( 16 17 1121 1122 O
albumin<3.5g 17 29 1122 1134 O
/ 29 30 1134 1135 I-upper_bound
dL 30 32 1135 1137 I-upper_bound
) 32 33 1137 1138 O

Hyponatremia 0 12 1139 1151 B-chronic_disease
( 13 14 1152 1153 O
sodium<135mmol 14 28 1153 1167 B-clinical_variable
/ 28 29 1167 1168 I-upper_bound
L 29 30 1168 1169 I-upper_bound
) 30 31 1169 1170 O

Immunohistochemical 0 19 1171 1190 O
evidence 20 28 1191 1199 O
of 29 31 1200 1202 O
KSHV 32 36 1203 1207 B-chronic_disease
in 37 39 1208 1210 O
tissues 40 47 1211 1218 O
( 48 49 1219 1220 O
for 49 52 1220 1223 O
example 53 60 1224 1231 O
by 61 63 1232 1234 O
staining 64 72 1235 1243 O
for 73 76 1244 1247 O
LANA 77 81 1248 1252 B-clinical_variable
or 82 84 1253 1255 O
vIL-6 85 90 1256 1261 B-clinical_variable
) 90 91 1261 1262 O
. 91 92 1262 1263 O
Confirmed 93 102 1264 1273 O
in 103 105 1274 1276 O
the 106 109 1277 1280 O
Laboratory 110 120 1281 1291 O
of 121 123 1292 1294 O
Pathology 124 133 1295 1304 O
, 133 134 1304 1305 O
CCR 135 138 1306 1309 O
, 138 139 1309 1310 O
NCI 140 143 1311 1314 O

KICS 0 4 1315 1319 B-chronic_disease
that 5 9 1320 1324 O
would 10 15 1325 1330 O
preclude 16 24 1331 1339 O
the 25 28 1340 1343 O
use 29 32 1344 1347 O
of 33 35 1348 1350 O
all 36 39 1351 1354 O
of 40 42 1355 1357 O
the 43 46 1358 1361 O
study 47 52 1362 1367 O
treatments 53 63 1368 1378 O

Leukopenia 0 10 1379 1389 B-chronic_disease
( 11 12 1390 1391 O
white 12 17 1391 1396 B-clinical_variable
cell 18 22 1397 1401 I-clinical_variable
count<4,000 23 34 1402 1413 I-clinical_variable
cells 35 40 1414 1419 I-upper_bound
/ 40 41 1419 1420 I-upper_bound
microL 41 47 1420 1426 I-upper_bound
) 47 48 1426 1427 O

Molecular 0 9 1428 1437 O
evidence 10 18 1438 1446 O
of 19 21 1447 1449 O
KSHV 22 26 1450 1454 B-chronic_disease
in 27 29 1455 1457 O
whole 30 35 1458 1463 O
blood 36 41 1464 1469 O
, 41 42 1469 1470 O
confirmed 43 52 1471 1480 O
by 53 55 1481 1483 O
testing 56 63 1484 1491 O
at 64 66 1492 1494 O
Focus 67 72 1495 1500 O
Laboratories 73 85 1501 1513 O
, 85 86 1513 1514 O
CA 87 89 1515 1517 O
( 90 91 1518 1519 O
HHV-8 91 96 1519 1524 O
Quantitative 97 109 1525 1537 O
PCR 110 113 1538 1541 O
, 113 114 1541 1542 O
Focus 115 120 1543 1548 O
Unit 121 125 1549 1553 O
Code 126 130 1554 1558 O
45700 131 136 1559 1564 O
) 136 137 1564 1565 O

Nausea 0 6 1566 1572 B-chronic_disease
, 6 7 1572 1573 O
anorexia 8 16 1574 1582 B-chronic_disease
, 16 17 1582 1583 O
abdominal 18 27 1584 1593 B-chronic_disease
pain 28 32 1594 1598 I-chronic_disease
or 33 35 1599 1601 O
altered 36 43 1602 1609 B-chronic_disease
bowel 44 49 1610 1615 I-chronic_disease
habit 50 55 1616 1621 I-chronic_disease

Neuropathy 0 10 1622 1632 B-chronic_disease
with 11 15 1633 1637 O
or 16 18 1638 1640 O
without 19 26 1641 1648 O
pain 27 31 1649 1653 O

Pathologic 0 10 1654 1664 O
lymphadenopathy 11 26 1665 1680 B-chronic_disease
( 27 28 1681 1682 O
at 28 30 1682 1684 O
least 31 36 1685 1690 O
five 37 41 1691 1695 B-lower_bound
discrete 42 50 1696 1704 O
nodes 51 56 1705 1710 O
each 57 61 1711 1715 O
> 62 63 1716 1717 O
1 63 64 1717 1718 B-lower_bound
cm 64 66 1718 1720 I-lower_bound
in 67 69 1721 1723 O
their 70 75 1724 1729 O
longest 76 83 1730 1737 O
dimension 84 93 1738 1747 O
) 93 94 1747 1748 O

Pregnancy 0 9 1749 1758 B-pregnancy

Presence 0 8 1759 1767 O
of 9 11 1768 1770 O
KS 12 14 1771 1773 B-cancer
or 15 17 1774 1776 O
PEL 18 21 1777 1780 B-cancer
( 22 23 1781 1782 O
KSHV 23 27 1782 1786 B-cancer
- 27 28 1786 1787 I-cancer
associated 28 38 1787 1797 I-cancer
malignancies 39 51 1798 1810 I-cancer
) 51 52 1810 1811 O
, 52 53 1811 1812 O
confirmed 54 63 1813 1822 O
in 64 66 1823 1825 O
the 67 70 1826 1829 O
Laboratory 71 81 1830 1840 O
of 82 84 1841 1843 O
Pathology 85 94 1844 1853 O
, 94 95 1853 1854 O
CCR 96 99 1855 1858 O
, 99 100 1858 1859 O
NCI 101 104 1860 1863 O

Splenomegaly 0 12 1864 1876 B-clinical_variable
( 13 14 1877 1878 O
> 14 15 1878 1879 O
12 15 17 1879 1881 B-lower_bound
cm 18 20 1882 1884 I-lower_bound
in 21 23 1885 1887 O
the 24 27 1888 1891 O
longest 28 35 1892 1899 O
dimension 36 45 1900 1909 O
) 45 46 1909 1910 O

Thrombocytopenia 0 16 1911 1927 B-chronic_disease
( 17 18 1928 1929 O
platelets<100,000 18 35 1929 1946 B-clinical_variable
cells 36 41 1947 1952 I-upper_bound
/ 41 42 1952 1953 I-upper_bound
microL 42 48 1953 1959 I-upper_bound
) 48 49 1959 1960 O

